New York, NYCIK 19531074 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
7 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Zenas Biopharma Inc | 3.92M | $142.30M | 28.1% | +157.8K | Added |
| 2 | Immunome Inc | 4.77M | $102.43M | 20.2% | 0 | Held |
| 3 | Sionna Therapeutics Inc | 2.48M | $101.95M | 20.1% | 0 | Held |
| 4 | Upstream Bio Inc |
| 2.46M |
| $66.78M |
| 13.2% |
| 0 |
| Held |
| 5 | Compass Therapeutics Inc | 7.79M | $41.82M | 8.3% | 0 | Held |
| 6 | Bridgebio Oncology Therapeut | 2.63M | $32.89M | 6.5% | 0 | Held |
| 7 | Camp4 Therapeutics Corp | 3.04M | $18.61M | 3.7% | −750.0K | Reduced |